Vera Therapeutics, Inc.
US ˙ NasdaqGM ˙ US92337R1014

SecurityVERA / Vera Therapeutics, Inc.
InstitutionTd Asset Management Inc
Latest Disclosed Ownership193,994 shares
Latest Disclosed Value $ 7,804,379
Td Asset Management Inc reports 40.41% decrease in ownership of VERA / Vera Therapeutics, Inc.

On May 11, 2026 - Td Asset Management Inc filed a 13F-HR form disclosing ownership of 193,994 shares of Vera Therapeutics, Inc. (US:VERA) valued at $7,804,379 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 325,564 shares of Vera Therapeutics, Inc.. This represents a change in shares of -40.41% during the quarter. The current value of the position is $6,264,066 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F VERA THERAPEUTICS CL A 92337R101 193,994 -131,570 -40.41 7,804 -52.66 0.0034
2026-02-10 2025-12-31 13F VERA THERAPEUTICS CL A 92337R101 325,564 115,090 54.68 16,487 169.56 0.0133
2025-11-10 2025-09-30 13F VERA THERAPEUTICS CL A 92337R101 210,474 10,200 5.09 6,116 29.63 0.0050
2025-07-28 2025-06-30 13F VERA THERAPEUTICS CL A 92337R101 200,274 -51,890 -20.58 4,718 -22.09 0.0040
2025-05-07 2025-03-31 13F VERA THERAPEUTICS CL A 92337R101 252,164 21,606 9.37 6,057 -37.89 0.0056
2025-02-11 2024-12-31 13F VERA THERAPEUTICS CL A 92337R101 230,558 37,664 19.53 9,750 16.36 0.0086
2024-11-01 2024-09-30 13F VERA THERAPEUTICS CL A 92337R101 192,894 38,556 24.98 8,379 50.08 0.0074
2024-08-02 2024-06-30 13F VERA THERAPEUTICS CL A 92337R101 154,338 24,000 18.41 5,584 -0.66 0.0052
2024-05-08 2024-03-31 13F VERA THERAPEUTICS CL A 92337R101 130,338 130,338 5,620 0.0052
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.